You are here

PureTech

PureTech's lung fibrosis drug slows decline in phase 2 trial

Fierce Biotech

Mon, 12/16/24 - 11:32 am

clinical trials

Royalty Pharma hands off $100M upfront for PureTech royalty on Karuna's schizophrenia hopeful

Endpoints

Thu, 03/23/23 - 11:49 am

Karuna Therapeutics

Nektar and PureTech merger talks called off

Pharmaforum

Tue, 10/11/22 - 10:40 am

Nektar Therapeutics

Puretech-backed Karuna makes Nasdaq debut with $89M IPO

Endpoints

Sat, 06/29/19 - 02:31 pm

PureTech, Boehringer partner to develop lymph node-targeting cancer immunotherapies

BioCentury

Thu, 04/18/19 - 09:50 am

Boehringer Ingelheim

lymphatic targeting

PureTech Receives Up To $36 Million from Roche to Develop Oral Delivery of Antisense Oligonucleotides

CP Wire

Fri, 07/20/18 - 11:29 am

drug development

PureTech Receives Up To $36 Million from Roche to Develop Oral Delivery of Antisense Oligonucleotides

Fri, 07/20/18 - 09:43 am

In an end-of-year IPO blitz, 4 biotechs pitch new offerings totaling $370M

Endpoints

Tue, 01/2/18 - 07:41 pm

ARMO BioSciences

Menlo Therapeutics

Solid Biosciences